Impact on the Adverse Event (AE) Incidence of Two Types of Experience Feedback on AE Analyzed During Local Morbidity Mortality Reviews
- Conditions
- Hospital Adverse Event
- Registration Number
- NCT02771613
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
After implementing a French version of a trigger tool validated for computerized detection of adverse events in patient's medical record, the study will be performed in three parallel randomized arms of three identical departments (each steaming from 6 types of medical, surgical or obstetrical departments with a total of 18 departments involved). This three arms will be: no intervention, education of department's staff by multi professional in situ simulation (adapted to the discovered adverse events), or simple but large diffusion of results and decisions of Morbidity Mortality Reviews.
The interventions will be performed during a two-years period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 144000
- patients aged > 18 years old
- patients hospitalized in the involved departments during the two-years intervention's period
- patient aged < 18 years old
- no other exclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurence of adverse events related to medical care During patient hospitalization, up to 2 years Occurrence of any adverse effects detected by the trigger tool. Trigger tool is used to detect more patient's adverse events that voluntary medical report
- Secondary Outcome Measures
Name Time Method Contributive factors identification During patient hospitalization, up to 2 years Contributive factors of adverse events using the "ALARM Method". The Alarm Method allows to determine the contributive factors which together create the adverse patients events.
Severity of adverse events related to medical care During patient hospitalization, up to 2 years Severity of any patient's adverse effect detected by trigger tool. Severity of adverse events is measured by a severity score scale.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Hospices Civils de Lyon - Direction DOQRU
🇫🇷Lyon, France
Hospices Civils de Lyon - Direction DOQRU🇫🇷Lyon, FranceBernard BUI-XUAN, MD, PhDPrincipal InvestigatorPhilippe MICHEL, MD, PhDContact+33 4 72 40 71 03philippe.michel@chu-lyon.fr